BE2014C049I2 - Circovirus sequences associated with piglet weight loss disease (PWD) - Google Patents

Circovirus sequences associated with piglet weight loss disease (PWD)

Info

Publication number: BE2014C049I2
Authority: BE; Belgium
Prior art keywords: pwd; circovirus; polypeptides; vectors; weight loss
Prior art date: 1997-12-05

Application number

BE2014C049C

Other languages

English (en)

French (fr)

Original Assignee

Zoetis Services Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-12-05

Filing date

2014-08-14

Publication date

2018-07-04

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9514225&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE2014C049(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-08-14 Application filed by Zoetis Services Llc filed Critical Zoetis Services Llc

2018-07-04 Publication of BE2014C049I2 publication Critical patent/BE2014C049I2/fr

Links

241001533384 Circovirus Species 0.000 title abstract 5
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
208000016261 weight loss Diseases 0.000 title 1
230000004580 weight loss Effects 0.000 title 1
229920001184 polypeptide Polymers 0.000 abstract 3
102000004196 processed proteins & peptides Human genes 0.000 abstract 3
108090000765 processed proteins & peptides Proteins 0.000 abstract 3
239000013598 vector Substances 0.000 abstract 3
208000036142 Viral infection Diseases 0.000 abstract 2
230000009385 viral infection Effects 0.000 abstract 2
241001465754 Metazoa Species 0.000 abstract 1
108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
201000010099 disease Diseases 0.000 abstract 1
208000015181 infectious disease Diseases 0.000 abstract 1
239000000203 mixture Substances 0.000 abstract 1
108020004707 nucleic acids Proteins 0.000 abstract 1
102000039446 nucleic acids Human genes 0.000 abstract 1
150000007523 nucleic acids Chemical class 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/58—Medicinal preparations containing antigens or antibodies raising an immune response against a target which is not the antigen used for immunisation
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10051—Methods of production or purification of viral material
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10061—Methods of inactivation or attenuation
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/01—DNA viruses
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2469/00—Immunoassays for the detection of microorganisms
- G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/13—Hollow or container type article [e.g., tube, vase, etc.]

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Microbiology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Bioinformatics & Cheminformatics (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Tropical Medicine & Parasitology (AREA)
General Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Mycology (AREA)
Epidemiology (AREA)
Gastroenterology & Hepatology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Cell Biology (AREA)
Pathology (AREA)

BE2014C049C 1997-12-05 2014-08-14 Circovirus sequences associated with piglet weight loss disease (PWD) BE2014C049I2 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9715396A FR2772047B1 (fr)	1997-12-05	1997-12-05	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
PCT/FR1998/002634 WO1999029871A2 (fr)	1997-12-05	1998-12-04	Sequences de circovirus associe a la maladie de l'amaigrissement du porcelet (map)

Publications (1)

Publication Number	Publication Date
BE2014C049I2 true BE2014C049I2 (en)	2018-07-04

Family

ID=9514225

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
BE2014C049C BE2014C049I2 (en)	1997-12-05	2014-08-14	Circovirus sequences associated with piglet weight loss disease (PWD)
BE2014C050C BE2014C050I2 (en)	1997-12-05	2014-08-14	Circovirus sequences associated with piglet weight loss disease (PWD)

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
BE2014C050C BE2014C050I2 (en)	1997-12-05	2014-08-14	Circovirus sequences associated with piglet weight loss disease (PWD)

Country Status (15)

Country	Link
US (43)	US6703023B1 (da)
EP (6)	EP2330188B1 (da)
AT (1)	ATE412664T1 (da)
AU (1)	AU1491699A (da)
BE (2)	BE2014C049I2 (da)
CY (6)	CY1115405T1 (da)
DE (1)	DE69840174D1 (da)
DK (5)	DK2330188T3 (da)
ES (5)	ES2456959T3 (da)
FR (3)	FR2772047B1 (da)
HK (1)	HK1222415A1 (da)
LU (2)	LU92523I2 (da)
NL (2)	NL300686I2 (da)
PT (5)	PT2000535E (da)
WO (1)	WO1999029871A2 (da)

Families Citing this family (72)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6517843B1 (en) *	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6391314B1 (en)	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
US7192594B2 (en)	1997-10-03	2007-03-20	Merial Limited	Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US7211379B2 (en)	1997-10-03	2007-05-01	Merial Sas	Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
AU2003248395B2 (en) *	1997-10-03	2006-03-16	Merial	Porcine CircoViruses, vaccines and diagnostic reagents
AU2002302120B2 (en) *	1997-10-03	2006-01-19	Merial	Porcine circoviruses, vaccines and diagnostic reagents
FR2772047B1 (fr) *	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
JP3795751B2 (ja) *	1997-12-11	2006-07-12	ユニバーシティオブサスカッチェワン	ブタからの離乳後多全身系消耗症候群ウイルス
EP1816200B1 (en) *	1997-12-11	2016-03-09	Merial	Postweaning multisystemic wasting syndrome virus for pigs
EP1064024A4 (en) *	1998-03-13	2005-04-06	Univ Georgia Res Found	VACCINES AGAINST CIRCOVIRUS INFECTIONS
US6943152B1 (en) *	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
ES2170622B1 (es) *	1999-12-03	2004-05-16	Consejo Superior De Investigaciones Cientificas	Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
AU2001238535A1 (en)	2000-02-16	2001-08-27	Large Scale Biology Corporation	Rolling circle replicon expression vectors
CN1309836C (zh)	2001-03-27	2007-04-11	萨斯喀彻温大学	培养环状病毒的方法
US7276353B2 (en) *	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7279166B2 (en)	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7833707B2 (en) *	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
HUE025537T2 (en)	2004-12-30	2016-05-30	Boehringer Ingelheim Vetmedica Inc	PCV2-immunogenic compositions and methods for preparing such compositions
AU2011253941B2 (en) *	2004-12-30	2015-01-29	Boehringer Ingelheim Animal Health USA Inc.	PCV2 immunogenic compositions and methods of producing such compositions
UA95602C2 (ru)	2004-12-30	2011-08-25	Берингер Ингельхейм Ветмедика, Инк.	Иммуногенная композиция цвс2 и способы приготовления такой композиции
US7700285B1 (en)	2005-12-29	2010-04-20	Boehringer Ingelheim Vetmedica, Inc.	PCV2 immunogenic compositions and methods of producing such compositions
ITBO20050123A1 (it)	2005-03-07	2005-06-06	Alfa Wassermann Spa	Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
US8834891B2 (en)	2005-03-14	2014-09-16	Boehringer Ingelheim Vetmedica, Inc.	Immunogenic compositions comprising Lawsonia intracellularis
WO2006132598A1 (en) *	2005-06-07	2006-12-14	Temasek Life Sciences Laboratory Limited	Porcine circovirus type 2 vaccines
KR101347503B1 (ko) *	2005-09-09	2014-01-02	인터벳 인터내셔널 비.브이.	Ｐｃｖ-2 백신
EP1968630B1 (en)	2005-12-29	2018-01-24	Boehringer Ingelheim Vetmedica, Inc.	Multivalent pcv2 immunogenic compositions
MX338626B (es) *	2005-12-29	2016-04-26	Boehringer Ingelheim Vetmed	Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
EP2099927A4 (en) *	2006-11-22	2010-05-05	Boehringer Ingelheim Vetmed	Methods of reducing porcine circovirus-associated disease outbreaks
EP2859900A1 (en)	2006-12-11	2015-04-15	Boehringer Ingelheim Vetmedica, Inc.	Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
JP5200223B2 (ja) *	2006-12-15	2013-06-05	ベーリンガーインゲルハイムフェトメディカインコーポレイテッド	Ｐｃｖ２抗原によるブタの処置
EP1941903A1 (en) *	2007-01-03	2008-07-09	Boehringer Ingelheim Vetmedica Gmbh	Prophylaxis and treatment of PRDC
EP1958644A1 (en)	2007-02-13	2008-08-20	Boehringer Ingelheim Vetmedica Gmbh	Prevention and treatment of sub-clinical pcvd
CN101688185B (zh) *	2007-05-11	2013-05-22	淡马锡生命科学研究院有限公司	对2型猪环状构象病毒(pcv2)感染高度容许的均质细胞系的产生
US7829274B2 (en)	2007-09-04	2010-11-09	Boehringer Ingelheim Vetmedica, Inc.	Reduction of concomitant infections in pigs by the use of PCV2 antigen
CA2710247C (en) *	2007-12-21	2014-02-18	Wyeth Llc	Methods and compositions for immunizing pigs against porcine circovirus
WO2009088950A2 (en) *	2007-12-31	2009-07-16	Boehringer Ingelheim Vetmedica, Inc.	Pcv2 orf2 virus like particle with foreign amino acid insertion
KR20100113582A (ko) *	2008-01-23	2010-10-21	베링거잉겔하임베트메디카인코퍼레이티드	Ｐｃｖ2 마이코플라즈마 히오뉴모니에 면역원성 조성물 및 당해 조성물의 생산 방법
US20110033495A1 (en) *	2008-02-15	2011-02-10	Boehringer Ingelheim Vetmedica, Inc.	Methods and compositions for reducing the impact of enteric diseases
CN102256997A (zh) *	2008-10-16	2011-11-23	美国辉瑞有限公司	细环病毒分离株和组合物
WO2011046634A1 (en) *	2009-10-16	2011-04-21	Pfizer, Inc.	Infectious clones of torque teno virus
US20100150959A1 (en) *	2008-12-15	2010-06-17	Vectogen Pty Ltd.	PCV 2-Based Methods and Compositions for the Treatment of Pigs
AR078253A1 (es)	2009-09-02	2011-10-26	Boehringer Ingelheim Vetmed	Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
AR078502A1 (es)	2009-10-02	2011-11-09	Pioneer Hi Bred Int	Regulacion hacia abajo de acc (acido 1-aminociclopropano-1-carboxilico) sintasa para el rendimiento mejorado de plantas
US8846388B2 (en)	2009-10-16	2014-09-30	Zoetis Llc	Infectious clones of torque teno virus
CN102711816A (zh) *	2009-10-22	2012-10-03	莱比锡大学	患有牛新生儿全血细胞减少症的小牛中的圆环病毒的检测
WO2011091389A2 (en) *	2010-01-25	2011-07-28	Blood Systems, Inc.	Cyclovirus and method of use
KR20110090711A (ko) *	2010-02-04	2011-08-10	녹십자수의약품(주)	신규한 돼지 써코바이러스 타입 2 및 그의 용도
TWI442935B (zh)	2010-12-22	2014-07-01	Sbc Virbac Ltd	豬第二型環狀病毒（ＰｏｒｃｉｎｅＣｉｒｃｏｖｉｒｕｓＴｙｐｅ２）、含彼之免疫組合物、檢測套組及其應用
WO2012148835A1 (en)	2011-04-29	2012-11-01	Pioneer Hi-Bred International, Inc.	Down-regulation of a homeodomain-leucine zipper i-class homeobox gene for improved plant performance
HUP1100470A2 (en)	2011-08-30	2013-03-28	Mezoegazdasagi Biotechnologiai Kutatokoezpont	Nanoparticle-based veterinary vaccine
EP2564869A1 (en) *	2011-09-02	2013-03-06	Ceva Sante Animale	Synthetic capsid proteins and uses thereof
UA113192C2 (xx) *	2011-12-06	2016-12-26		Імуногенна композиція проти цирковірусу свиней типу 2 (pcv2)
UA114503C2 (uk)	2012-04-04	2017-06-26	Зоетіс Сервісіз Ллс	Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en)	2012-04-04	2015-09-01	Zoetis Services Llc	Mycoplasma hyopneumoniae vaccine
EP2961766B1 (en)	2013-03-01	2019-04-10	Boehringer Ingelheim Vetmedica, Inc.	Quantification of vaccine compositions
KR102217387B1 (ko) *	2013-03-11	2021-02-19	주식회사 중앙백신연구소	재조합 효모 전세포(yeast whole cell)을 이용한 돼지 써코바이러스(PCV2) 서브유닛 백신과 그의 제조 방법
EP2789346A1 (en)	2013-04-11	2014-10-15	CEVA Santé Animale SA	Fusion polypeptides and vaccines
ES2882374T3 (es)	2013-05-08	2021-12-01	Pharmgate Biologics Inc	Vacuna para PCV2 y micoplasma
EP3049106A1 (en)	2013-09-25	2016-08-03	Zoetis Services LLC	Pcv2b divergent vaccine composition and methods of use
US9505808B2 (en)	2013-10-02	2016-11-29	Boehringer Ingelheim Vetmedica, Inc.	PCV2 ORF2 protein variant and virus like particles composed thereof
EP3034609A1 (en)	2014-12-19	2016-06-22	Ceva Sante Animale	Recombinant swinepox virus and vaccines
EP3254692A1 (en)	2016-06-10	2017-12-13	Ceva Sante Animale	Multivalent recombinant spv
WO2019032830A1 (en)	2017-08-09	2019-02-14	Dreamwell, Ltd.	ADJUSTABLE SUPPORT STRUCTURE
EP3720485A1 (en)	2017-12-08	2020-10-14	Ceva Sante Animale	Recombinant swinepox virus and vaccines
CN119488586A (zh)	2018-03-26	2025-02-21	勃林格殷格翰动物保健美国有限公司	制备免疫原性组合物的方法
CN112292149A (zh)	2018-06-11	2021-01-29	法国诗华大药厂	针对猪圆环病毒的疫苗接种
US20230366043A1 (en) *	2020-10-06	2023-11-16	Materials and Machines Corporation of America	Method for detection of rna or dna from bological samples
WO2023192936A2 (en) *	2022-03-30	2023-10-05	Fred Hutchinson Cancer Center	Systems and methods to produce b cells that express selected antibodies and gene products
CN114736310B (zh) *	2022-06-10	2022-10-28	北京华夏兴洋生物科技有限公司	产生圆环病毒2型病毒样颗粒的蛋白质及生物材料与应用
CN121463956A (zh)	2023-05-03	2026-02-03	勃林格殷格翰动物保健有限公司	诱导免疫应答的方法
EP4704977A1 (en)	2023-05-03	2026-03-11	Boehringer Ingelheim Vetmedica GmbH	Immunogenic composition useful for self-administration by pigs

Family Cites Families (112)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US69233A (en) *		1867-09-24		Joseph r
US69750A (en) *		1867-10-15		Henry bean
FR2422956A1 (fr)	1978-04-13	1979-11-09	Pasteur Institut	Procede de detection et de caracterisation d'un acide nucleique ou d'une sequence de celui-ci, et reactif enzymatique pour la mise en oeuvre de ce procede
FR2464269B1 (fr)	1979-08-30	1986-04-18	Anvar	Sequence nucleotidique codant l'antigene de surface du virus de l'hepatite b, procede permettant son obtention et antigene obtenu
FR2518755B1 (fr)	1981-12-23	1986-04-11	Pasteur Institut	Sonde contenant un acide nucleique modifie et reconnaissable par des anticorps specifiques et utilisation de cette sonde pour detecter et caracteriser une sequence d'adn homologue
US5833975A (en)	1989-03-08	1998-11-10	Virogenetics Corporation	Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
US4745051A (en)	1983-05-27	1988-05-17	The Texas A&M University System	Method for producing a recombinant baculovirus expression vector
US4946787A (en)	1985-01-07	1990-08-07	Syntex (U.S.A.) Inc.	N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US5550289A (en)	1985-01-07	1996-08-27	Syntex (U.S.A.) Inc.	N-(1,(1-1)-dialkyloxy)-and N-(1,(1-1)-dialkenyloxy alk-1-yl-N-N,N-tetrasubstituted ammonium lipids and uses therefor
US5106733A (en)	1987-06-25	1992-04-21	Immunex Corporation	Bovine granulocyte-macrophage colony stimulating factor
SU1538305A1 (ru)	1987-07-21	1994-12-15	Всесоюзный государственный научно-контрольный институт ветеринарных препаратов Госагропрома СССР	Ассоциированная вакцина против лептоспироза и парвовирусной инфекции свиней
US5069901A (en)	1988-02-03	1991-12-03	Jones Elaine V	Preparation of a recombinant subunit vaccine against pseudorabies infection
DE69027112T2 (de)	1989-01-23	1997-01-09	Auspharm International Ltd 4Th	Impfstoffzusammensetzung
US5811103A (en)	1989-03-19	1998-09-22	Akzo Nobel N.V.	Hog cholera virus vaccine and diagnostic
CA2489769A1 (en)	1989-03-21	1990-10-04	Philip L. Felgner	Expression of exogenous polynucleotide sequences in a vertebrate
US5703055A (en)	1989-03-21	1997-12-30	Wisconsin Alumni Research Foundation	Generation of antibodies through lipid mediated DNA delivery
US5800992A (en)	1989-06-07	1998-09-01	Fodor; Stephen P.A.	Method of detecting nucleic acids
US5264618A (en)	1990-04-19	1993-11-23	Vical, Inc.	Cationic lipids for intracellular delivery of biologically active molecules
CA2082155C (en)	1990-05-29	2008-04-15	Krishnaswamy I. Dayalu	Swine pneumonia vaccine and method of preparation
US5565205A (en)	1990-08-16	1996-10-15	Solvay Animal Health, Inc.	Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
WO1992005255A1 (en)	1990-09-13	1992-04-02	Commonwealth Scientific And Industrial Research Organisation	Ovine cytokine genes
GB9023111D0 (en) *	1990-10-24	1990-12-05	Wellcome Found	Expression system
CA2094515C (en)	1990-11-01	1998-09-01	Theodore T. Kramer	Bacterial attenuation method and vaccine
DE69233158T2 (de)	1991-03-07	2004-05-13	Connaught Technology Corp., Greenville	Gentechnologisch hergestellter stamm für impfstoffe
ES2026827A6 (es)	1991-03-26	1992-05-01	Ercros Sa	Procedimiento para la produccion de una vacuna subunidad contra el parvovirus porcino.
US5580557A (en) *	1991-10-09	1996-12-03	Iowa State University Research Foundation, Inc.	Live, avirulent salmonella choleraesuis vaccine used for inducing an immune response in animals
US6033904A (en)	1992-01-13	2000-03-07	Syntro Corporation	Recombinant swinepox virus
US5382425A (en)	1992-01-13	1995-01-17	Syntro Corporation	Recombinant swinepox virus
US5338543A (en)	1992-02-27	1994-08-16	Ambico, Inc.	Thimerosal inactivated mycoplasma hyopneumoniae vaccine
AU4662393A (en)	1992-07-08	1994-01-31	Schering Corporation	Use of gm-csf as a vaccine adjuvant
JP3149116B2 (ja) *	1992-10-28	2001-03-26	信越化学工業株式会社	ヒトパルボウイルスのエピトープ関連ペプチド
ATE275191T1 (de) *	1992-11-09	2004-09-15	Zonagen Inc	Methoden für die immunoempfängnisverhütung
KR100374295B1 (ko)	1993-02-08	2003-12-24	바이엘 코포레이션	돼지생식및호흡증후군바이러스의생육방법과백신에서그의용도
EP0620277A1 (en)	1993-03-18	1994-10-19	Merck & Co. Inc.	Nucleic acid pharmaceuticals
EP0698245A1 (en)	1993-05-14	1996-02-28	Mds Health Group Limited	Electronic worksheet system for microbiology testing and reporting
EP1624068A1 (en)	1993-06-01	2006-02-08	Life Technologies Inc.	Genetic immunization with cationic lipids
JP3626187B2 (ja)	1993-06-07	2005-03-02	バイカルインコーポレイテッド	遺伝子治療に適するプラスミド
US6015686A (en)	1993-09-15	2000-01-18	Chiron Viagene, Inc.	Eukaryotic layered vector initiation systems
FR2711670B1 (fr)	1993-10-22	1996-01-12	Pasteur Institut	Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
GB2285766B (en)	1994-01-21	1997-07-23	Ecc Int Ltd	Ceramic casting composition
KR0121105B1 (ko) *	1994-02-04	1997-11-10	문정환	선입선출메모리 버스장치
EP0804249A2 (en)	1994-03-15	1997-11-05	Brown University Research Foundation	Polymeric gene delivery system
ATE298370T1 (de)	1994-04-29	2005-07-15	Baxter Healthcare Sa	Rekombinante poxviren mit fremdenpolynukleotiden in wichtigen regionen
PT759780E (pt)	1994-05-10	2001-01-31	American Home Prod	Vacina melhorada de vsrb vivo modificado
GB2289279B (en)	1994-05-13	1998-09-16	Iberica Cyanamid	Diagnostic kits and vaccines containing recombinant PRRSV proteins
US5719131A (en)	1994-12-09	1998-02-17	Genzyme Corporation	Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
US5840306A (en) *	1995-03-22	1998-11-24	Merck & Co., Inc.	DNA encoding human papillomavirus type 18
US6043232A (en)	1997-07-23	2000-03-28	Nitromed, Inc.	Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs
JPH11504631A (ja)	1995-04-25	1999-04-27	バイカルインコーポレイテッド	Ｄｎａ／脂質複合体の単一バイアル製剤
US5681658A (en) *	1995-05-30	1997-10-28	Aluminum Company Of America	Gelation-resistant alumina
US5885823A (en)	1995-06-05	1999-03-23	Nobl Laboratories, Inc.	Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents
US6019980A (en)	1995-06-07	2000-02-01	Connaught Laboratories Limited	Nucleic acid respiratory syncytial virus vaccines
US5705385A (en)	1995-06-07	1998-01-06	Inex Pharmaceuticals Corporation	Lipid-nucleic acid particles prepared via a hydrophobic lipid-nucleic acid complex intermediate and use for gene transfer
US5820869A (en)	1995-06-07	1998-10-13	American Home Products Corporation	Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
NZ309172A (en)	1995-06-07	1999-11-29	Leadd B	Neutralizing conformational epitopes of chicken anemia virus
US5795872A (en)	1995-09-19	1998-08-18	Pharmadigm, Inc.	DNA construct for immunization
FR2751224B1 (fr)	1996-07-19	1998-11-20	Rhone Merieux	Formule de vaccin polynucleotidique contre les pathologies respiratoires et de reproduction des porcs
ATE199022T1 (de)	1996-10-09	2001-02-15	Akzo Nobel Nv	Europäische vakzinstämme des fortplanzungs- atmungs-syndromsvirus des sweins (prrsv)
WO1998040499A1 (en)	1997-03-10	1998-09-17	Heather Lynn Davis	Gene delivery to mucosal epithelium for immunization or therapeutic purposes
US5990091A (en)	1997-03-12	1999-11-23	Virogenetics Corporation	Vectors having enhanced expression, and methods of making and uses thereof
US6004777A (en)	1997-03-12	1999-12-21	Virogenetics Corporation	Vectors having enhanced expression, and methods of making and uses thereof
US20030215445A1 (en) *	1997-05-23	2003-11-20	Ginette Serrero	Methods and compositions for inhibiting the growth of hematopoietic malignant cells
US6517843B1 (en) *	1999-08-31	2003-02-11	Merial	Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2769321B1 (fr)	1997-10-03	2001-10-26	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostics
UA78180C2 (uk) *	1997-10-03	2007-03-15	Меріаль	Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US6391314B1 (en) *	1997-10-03	2002-05-21	Merial	Porcine circoviruses vaccines diagnostic reagents
US6143334A (en) *	1997-10-03	2000-11-07	Sargento Foods Inc.	Pasta filata method for manufacturing Swiss-type cheeses
US7192594B2 (en) *	1997-10-03	2007-03-20	Merial Limited	Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US7211379B2 (en)	1997-10-03	2007-05-01	Merial Sas	Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
FR2769322B1 (fr)	1997-10-03	2002-03-08	Merial Sas	Nouveaux circovirus porcins, vaccins et reactifs de diagnostic
FR2781159B1 (fr) *	1998-07-06	2000-10-06	Merial Sas	Vaccin circovirus et parvovirus porcin
US6165493A (en)	1997-10-22	2000-12-26	New York Blood Center, Inc.	"Methods and compositions for decreasing the frequency of HIV, herpesvirus and sexually transmitted bacterial infections"
US20040062775A1 (en)	1997-12-05	2004-04-01	Agence Francaise De Securite Sanitaire Des Aliments	Circovirus sequences associated with piglet weight loss disease (PWD)
FR2772047B1 (fr)	1997-12-05	2004-04-09	Ct Nat D Etudes Veterinaires E	Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection
JP3795751B2 (ja) *	1997-12-11	2006-07-12	ユニバーシティオブサスカッチェワン	ブタからの離乳後多全身系消耗症候群ウイルス
EP1064024A4 (en) *	1998-03-13	2005-04-06	Univ Georgia Res Found	VACCINES AGAINST CIRCOVIRUS INFECTIONS
US6294176B1 (en)	1998-07-10	2001-09-25	Schering-Plough Veterinary Corp.	Recombinant raccoonpox virus and uses thereof as a vaccine in mammalian and avian species
AU1131200A (en)	1998-10-23	2000-05-15	Heska Corporation	Cationic lipid-mediated enhancement of nucleic acid immunization of cats
US6143333A (en)	1998-11-13	2000-11-07	Purina Mills, Inc.	Method of preparing a packaged fish attractant block
FR2789695B1 (fr)	1999-02-11	2003-03-07	Merial Sas	Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en)	1999-06-10	2005-09-13	Merial	DNA vaccine-PCV
US6497883B1 (en)	1999-06-10	2002-12-24	Merial	Porcine circovirus recombinant poxvirus vaccine
US6179461B1 (en)	1999-09-03	2001-01-30	Davis-Standard Corporation	Extruder screw
US6139179A (en)	1999-09-03	2000-10-31	Davis-Standard Corporation	Extruder screw having multi-channeled barrier section
WO2001017556A1 (fr)	1999-09-07	2001-03-15	Shionogi & Co., Ltd.	Préparations vaccinales administrables par les muqueuses
GB9921147D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
GB9921146D0 (en)	1999-09-07	1999-11-10	Smithkline Beecham Biolog	Novel composition
DE50009644D1 (de) *	1999-11-10	2005-04-07	Rodenstock Gmbh	Heterocyclisch annellierte indenochromenderivate
US6366601B1 (en) *	1999-11-17	2002-04-02	Motorola, Inc.	Variable rate spread spectrum communication method and apparatus
US7233407B1 (en) *	2000-02-02	2007-06-19	Xerox Corporation	Document production system for capturing web page content
JP3363419B2 (ja) *	1999-12-24	2003-01-08	住友ゴム工業株式会社	重荷重用ラジアルタイヤ
JP2004503234A (ja)	2000-06-15	2004-02-05	パーデュー・リサーチ・ファウンデーション	ブタの先天性振せん用ワクチン
JP4768106B2 (ja)	2000-07-31	2011-09-07	スリーエムイノベイティブプロパティズカンパニー	接着剤組成物及び熱剥離容易な接着構造
DE10044648A1 (de)	2000-09-08	2002-03-21	Aventis Behring Gmbh	Verfahren zur Vermehrung oder zur Entfernung von Cirocoviren aus biologischem Material
DE10044646A1 (de)	2000-09-08	2002-04-04	Horsch Maschinen Gmbh	Spritzgestängeführung
DE10051562A1 (de) *	2000-10-18	2002-04-25	Emitec Emissionstechnologie	Beheizbarer Wabenkörper mit zwei verschiedenen Beschichtungen
US6572081B2 (en) *	2000-12-27	2003-06-03	Nkf Kabel B.V.	Installation of guide tubes in a protective duct
CN1309836C (zh) *	2001-03-27	2007-04-11	萨斯喀彻温大学	培养环状病毒的方法
AUPR567401A0 (en)	2001-06-14	2001-07-12	University Of Melbourne, The	Circovirus vaccines
US7279166B2 (en)	2001-12-12	2007-10-09	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US7276353B2 (en) *	2001-12-12	2007-10-02	Virginia Tech Intellectual Properties, Inc.	Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
US20030215455A1 (en)	2002-05-14	2003-11-20	Bailey Reynolds	Vaccine stabilizer and method of use
CN1695268A (zh) *	2002-11-28	2005-11-09	捷讯研究有限公司	具有贴片和隙缝结构的多频带天线
US7288529B2 (en) *	2003-04-24	2007-10-30	New York University	ALK protein tyrosine kinase, cells and methods embodying and using same
KR101131845B1 (ko)	2003-07-25	2012-03-30	베링거잉겔하임베트메디카인코퍼레이티드	유럽 기원의 로소니아 인트라셀룰라리스, 및 이의 백신,진단제 및 사용 방법
US20050279889A1 (en)	2004-06-08	2005-12-22	Safe Flight Instrument Corporation	Variable wing spacecraft
US7833707B2 (en) *	2004-12-30	2010-11-16	Boehringer Ingelheim Vetmedica, Inc.	Methods of overexpression and recovery of porcine circovirus type 2 ORF2
KR20070096019A (ko) *	2005-01-13	2007-10-01	베링거잉겔하임베트메디카게엠베하	향상된 ｐｒｒｓ 백신
DK1869471T3 (da)	2005-04-13	2016-08-01	Merial Inc	Fremgangsmåde til fremstilling af svine-circovirus
MX338626B (es) *	2005-12-29	2016-04-26	Boehringer Ingelheim Vetmed	Uso de una composicion inmunogenica de pcv2 para producir los sintomas clinicos en cerdos.
US8377070B2 (en) *	2007-05-17	2013-02-19	Michael T. Gauthier	Compressor distractor tool
US8214576B2 (en)	2009-03-03	2012-07-03	Vmware, Inc.	Zero copy transport for target based storage virtual appliances

1997
- 1997-12-05 FR FR9715396A patent/FR2772047B1/fr not_active Expired - Lifetime
1998
- 1998-12-04 EP EP10184626.9A patent/EP2330188B1/fr not_active Expired - Lifetime
- 1998-12-04 EP EP08154912.3A patent/EP2000535B1/fr not_active Expired - Lifetime
- 1998-12-04 ES ES08154912.3T patent/ES2456959T3/es not_active Expired - Lifetime
- 1998-12-04 ES ES98958957T patent/ES2317679T5/es not_active Expired - Lifetime
- 1998-12-04 DK DK10184626.9T patent/DK2330188T3/da active
- 1998-12-04 DK DK08154913.1T patent/DK1992696T3/da active
- 1998-12-04 PT PT81549123T patent/PT2000535E/pt unknown
- 1998-12-04 EP EP98958957A patent/EP1036180B2/fr not_active Expired - Lifetime
- 1998-12-04 PT PT101846269T patent/PT2330188E/pt unknown
- 1998-12-04 AT AT98958957T patent/ATE412664T1/de active
- 1998-12-04 WO PCT/FR1998/002634 patent/WO1999029871A2/fr not_active Ceased
- 1998-12-04 ES ES10184556.8T patent/ES2548145T3/es not_active Expired - Lifetime
- 1998-12-04 DK DK98958957.7T patent/DK1036180T4/da active
- 1998-12-04 DK DK10184556.8T patent/DK2316925T3/da active
- 1998-12-04 PT PT81549131T patent/PT1992696E/pt unknown
- 1998-12-04 ES ES10184626.9T patent/ES2548146T3/es not_active Expired - Lifetime
- 1998-12-04 PT PT98958957T patent/PT1036180E/pt unknown
- 1998-12-04 AU AU14916/99A patent/AU1491699A/en not_active Abandoned
- 1998-12-04 EP EP15172572.8A patent/EP3002331A1/fr not_active Withdrawn
- 1998-12-04 EP EP10184556.8A patent/EP2316925B1/fr not_active Expired - Lifetime
- 1998-12-04 ES ES08154913.1T patent/ES2458309T3/es not_active Expired - Lifetime
- 1998-12-04 DK DK08154912.3T patent/DK2000535T3/da active
- 1998-12-04 PT PT101845568T patent/PT2316925E/pt unknown
- 1998-12-04 EP EP08154913.1A patent/EP1992696B1/fr not_active Revoked
- 1998-12-04 DE DE69840174T patent/DE69840174D1/de not_active Expired - Lifetime
2000
- 2000-02-28 US US09/514,245 patent/US6703023B1/en not_active Expired - Lifetime
2003
- 2003-04-09 US US10/409,613 patent/US20040076635A1/en not_active Abandoned
- 2003-05-21 US US10/442,180 patent/US20040091502A1/en not_active Abandoned
- 2003-08-08 US US10/637,011 patent/US7223594B2/en not_active Expired - Lifetime
- 2003-11-21 US US10/718,266 patent/US7148015B2/en not_active Expired - Lifetime
- 2003-11-21 US US10/718,264 patent/US7179472B2/en not_active Expired - Lifetime
2004
- 2004-02-11 US US10/775,337 patent/US20050008651A1/en not_active Abandoned
2005
- 2005-07-08 US US11/176,667 patent/US7244433B2/en not_active Expired - Lifetime
- 2005-10-31 US US11/262,514 patent/US7261898B2/en not_active Expired - Lifetime
2006
- 2006-07-17 US US11/487,589 patent/US7407803B2/en not_active Expired - Fee Related
- 2006-07-19 US US11/488,926 patent/US7405075B2/en not_active Expired - Fee Related
- 2006-07-19 US US11/488,885 patent/US7297537B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,291 patent/US7740865B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,305 patent/US7323330B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,237 patent/US7722883B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,302 patent/US7390494B2/en not_active Expired - Fee Related
- 2006-10-27 US US11/588,306 patent/US7425444B2/en not_active Expired - Fee Related
2007
- 2007-11-01 US US11/979,296 patent/US7740866B2/en not_active Expired - Fee Related
- 2007-12-20 US US12/003,188 patent/US7741026B2/en not_active Expired - Fee Related
- 2007-12-28 US US12/003,558 patent/US7604808B2/en not_active Expired - Fee Related
2008
- 2008-07-03 US US12/216,410 patent/US7758865B2/en not_active Expired - Fee Related
- 2008-07-28 US US12/219,774 patent/US8715690B2/en not_active Expired - Fee Related
2009
- 2009-09-17 US US12/561,946 patent/US20100226934A1/en not_active Abandoned
- 2009-09-17 US US12/561,829 patent/US20100166791A1/en not_active Abandoned
- 2009-09-17 US US12/561,881 patent/US20100172924A1/en not_active Abandoned
- 2009-10-19 US US12/588,526 patent/US20110135677A1/en not_active Abandoned
- 2009-10-19 US US12/588,525 patent/US20110033489A1/en not_active Abandoned
- 2009-11-13 US US12/618,485 patent/US7951907B2/en not_active Expired - Fee Related
- 2009-12-11 US US12/636,180 patent/US20100215690A1/en not_active Abandoned
2010
- 2010-01-08 US US12/684,506 patent/US20100203072A1/en not_active Abandoned
- 2010-01-11 US US12/685,243 patent/US20100221276A1/en not_active Abandoned
- 2010-03-05 US US12/718,183 patent/US20100189735A1/en not_active Abandoned
- 2010-03-05 US US12/718,153 patent/US20100189732A1/en not_active Abandoned
- 2010-03-05 US US12/718,214 patent/US20100189743A1/en not_active Abandoned
- 2010-03-05 US US12/718,168 patent/US20100189734A1/en not_active Abandoned
- 2010-03-05 US US12/718,197 patent/US8124723B2/en not_active Expired - Fee Related
- 2010-03-05 US US12/718,158 patent/US20100189733A1/en not_active Abandoned
- 2010-04-28 US US12/768,897 patent/US20100209453A1/en not_active Abandoned
2011
- 2011-09-06 US US13/226,013 patent/US8415525B2/en not_active Expired - Fee Related
- 2011-10-20 US US13/277,582 patent/US8916353B2/en not_active Expired - Fee Related
2014
- 2014-04-11 CY CY20141100270T patent/CY1115405T1/el unknown
- 2014-05-05 CY CY20141100318T patent/CY1115424T1/el unknown
- 2014-08-14 NL NL300686C patent/NL300686I2/nl unknown
- 2014-08-14 NL NL300685C patent/NL300685I2/nl unknown
- 2014-08-14 BE BE2014C049C patent/BE2014C049I2/fr unknown
- 2014-08-14 BE BE2014C050C patent/BE2014C050I2/fr unknown
- 2014-08-18 LU LU92523C patent/LU92523I2/xx unknown
- 2014-08-18 LU LU92524C patent/LU92524I2/xx unknown
- 2014-08-19 FR FR14C0061C patent/FR14C0061I2/fr active Active
- 2014-08-19 FR FR14C0062C patent/FR14C0062I2/fr active Active
- 2014-08-19 CY CY2014036C patent/CY2014036I1/el unknown
- 2014-08-19 CY CY2014035C patent/CY2014035I1/el unknown
- 2014-11-14 US US14/541,268 patent/US9717784B2/en not_active Expired - Fee Related
- 2014-11-14 US US14/541,516 patent/US9700613B2/en not_active Expired - Fee Related
2015
- 2015-09-30 CY CY20151100872T patent/CY1116761T1/el unknown
- 2015-10-09 CY CY20151100916T patent/CY1116837T1/el unknown
2016
- 2016-09-07 HK HK16110634.3A patent/HK1222415A1/zh unknown
2017
- 2017-07-28 US US15/662,772 patent/US10052375B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
US7297537B2 (en)	2007-11-20
CY1116761T1 (el)	2017-03-15
US20100166791A1 (en)	2010-07-01
EP2000535B1 (fr)	2014-01-22
EP2330188B1 (fr)	2015-07-15
FR2772047B1 (fr)	2004-04-09
US7405075B2 (en)	2008-07-29
US20100203072A1 (en)	2010-08-12
US20180000927A1 (en)	2018-01-04
US8124723B2 (en)	2012-02-28
PT2316925E (pt)	2015-10-23
US9717784B2 (en)	2017-08-01
US7390494B2 (en)	2008-06-24
BE2014C050I2 (en)	2018-07-04
US20040091502A1 (en)	2004-05-13
HK1158694A1 (en)	2012-07-20
US20070041990A1 (en)	2007-02-22
LU92524I2 (fr)	2014-10-20
US20090162918A1 (en)	2009-06-25
US20100226934A1 (en)	2010-09-09
NL300686I2 (nl)	2022-03-22
US20100074919A1 (en)	2010-03-25
US20100209453A1 (en)	2010-08-19
EP1992696A1 (fr)	2008-11-19
ATE412664T1 (de)	2008-11-15
HK1158254A1 (en)	2012-07-13
EP1036180B2 (fr)	2011-11-02
US20040076635A1 (en)	2004-04-22
US7223594B2 (en)	2007-05-29
US7758865B2 (en)	2010-07-20
CY1115405T1 (el)	2017-01-04
US7722883B2 (en)	2010-05-25
US20070048780A1 (en)	2007-03-01
FR14C0062I1 (da)	2014-10-10
US9700613B2 (en)	2017-07-11
HK1126522A1 (en)	2009-09-04
DK1036180T4 (da)	2012-01-23
EP1036180B1 (fr)	2008-10-29
US20150182616A1 (en)	2015-07-02
AU1491699A (en)	1999-06-28
US20060083756A1 (en)	2006-04-20
US7425444B2 (en)	2008-09-16
NL300685I2 (nl)	2022-03-22
US20100221283A1 (en)	2010-09-02
US20070065925A1 (en)	2007-03-22
US7148015B2 (en)	2006-12-12
ES2456959T3 (es)	2014-04-24
US20070059324A1 (en)	2007-03-15
EP2330188A1 (fr)	2011-06-08
US7179472B2 (en)	2007-02-20
EP3002331A1 (fr)	2016-04-06
US20100215690A1 (en)	2010-08-26
US8715690B2 (en)	2014-05-06
ES2317679T3 (es)	2009-04-16
WO1999029871A3 (fr)	1999-08-19
US7740866B2 (en)	2010-06-22
US20090123490A1 (en)	2009-05-14
CY1116837T1 (el)	2017-03-15
FR14C0062I2 (fr)	2016-06-24
US6703023B1 (en)	2004-03-09
US7740865B2 (en)	2010-06-22
US20100172924A1 (en)	2010-07-08
DK2316925T3 (da)	2015-10-12
DK2330188T3 (da)	2015-10-19
DK2000535T3 (da)	2014-04-22
NL300686I1 (da)	2014-08-27
US8415525B2 (en)	2013-04-09
EP2000535A1 (fr)	2008-12-10
US20040265848A1 (en)	2004-12-30
EP1036180A2 (fr)	2000-09-20
US20100189736A1 (en)	2010-07-29
PT1992696E (pt)	2014-05-27
CY2014035I2 (el)	2016-04-13
ES2458309T3 (es)	2014-04-30
US7244433B2 (en)	2007-07-17
US20070041989A1 (en)	2007-02-22
US20050084497A1 (en)	2005-04-21
FR14C0061I2 (fr)	2016-06-24
PT2330188E (pt)	2015-10-23
EP2316925A1 (fr)	2011-05-04
NL300685I1 (da)	2014-08-27
US20100221276A1 (en)	2010-09-02
US20110135677A1 (en)	2011-06-09
US20100189733A1 (en)	2010-07-29
US7604808B2 (en)	2009-10-20
ES2317679T5 (es)	2012-02-24
US20070253971A1 (en)	2007-11-01
US20100189734A1 (en)	2010-07-29
US8916353B2 (en)	2014-12-23
FR2772047A1 (fr)	1999-06-11
DK1036180T3 (da)	2009-03-09
CY2014035I1 (el)	2016-04-13
US7323330B2 (en)	2008-01-29
US20070110767A1 (en)	2007-05-17
CY1115424T1 (el)	2016-04-13
LU92523I2 (fr)	2014-10-20
US20060222663A1 (en)	2006-10-05
US20120005768A1 (en)	2012-01-05
HK1125676A1 (en)	2009-08-14
US20090092627A1 (en)	2009-04-09
CY2014036I2 (el)	2016-04-13
US20110033489A1 (en)	2011-02-10
US20100189743A1 (en)	2010-07-29
US20070059325A1 (en)	2007-03-15
WO1999029871A2 (fr)	1999-06-17
US7951907B2 (en)	2011-05-31
US20080233147A1 (en)	2008-09-25
ES2548145T3 (es)	2015-10-14
HK1222415A1 (zh)	2017-06-30
PT2000535E (pt)	2014-05-02
US20150175668A1 (en)	2015-06-25
DK1992696T3 (da)	2014-05-19
US20120034630A1 (en)	2012-02-09
ES2548146T3 (es)	2015-10-14
US20100189732A1 (en)	2010-07-29
EP1992696B1 (fr)	2014-02-19
US7407803B2 (en)	2008-08-05
US10052375B2 (en)	2018-08-21
US20050008651A1 (en)	2005-01-13
US7261898B2 (en)	2007-08-28
DE69840174D1 (de)	2008-12-11
FR14C0061I1 (da)	2014-10-10
US20100189735A1 (en)	2010-07-29
US7741026B2 (en)	2010-06-22
PT1036180E (pt)	2009-02-10
US20040161410A1 (en)	2004-08-19
EP2316925B1 (fr)	2015-07-08
CY2014036I1 (el)	2016-04-13

Publication	Publication Date	Title
BE2014C049I2 (en)	2018-07-04	Circovirus sequences associated with piglet weight loss disease (PWD)
DE69526973T3 (de)	2010-01-07	Sequenzen von hepatitis-c-virus genotype 7, und deren verwendung als vorbeugende, therapeutische und diagnostische mittel
Ridpath et al.	1994	Segregation of bovine viral diarrhea virus into genotypes
DE69033425T3 (de)	2010-02-18	HCV-Isolat J-1
CA2005291A1 (en)	1990-06-30	Feline infectious peritonitis virus diagnostic tools
EP1167542A3 (en)	2003-12-17	Probe for diagnosing infectious disease arising from Enterococcus faecalis
CA2108466A1 (en)	1992-11-09	Hcv genomic sequences for diagnostics and therapeutics
CA2196555A1 (en)	1996-02-15	Vr-2332 viral nucleotide sequence and methods of use
ATE366314T1 (de)	2007-07-15	Infektioese rna virus-klone, vakzine und davon abgeleitete diagnostische assays
CA2193365A1 (en)	1996-01-11	Polynucleotide vaccine for papillomavirus
RU93058449A (ru)	1996-11-10	Hcv геномные последовательности для диагностических и терапевтических целей
ATE338821T1 (de)	2006-09-15	Strukturprotein von aav, seine herstellung und verwendung
ATE420190T1 (de)	2009-01-15	Rekombinanter lebendimpfstoff, der katzenherpesvirus typ i enthält, insbesondere für die behandlung von infektiöser bauchfellentzündung bei katzen
CA2045323A1 (en)	1991-12-26	Non-a, non-b hepatitis virus genomic cdna and antigen polypeptide
CA2215328A1 (en)	1996-10-03	Novel human cytomegalovirus dna sequences
EP0297378A3 (de)	1989-05-10	2,5-Dihydropyrrole
WO1999058639A3 (en)	1999-12-29	Structural proteins of fish pancreatic disease virus and uses thereof
CA2066998A1 (en)	1992-10-27	Recombinant varicella-zoster virus and process for constructing same
Banks	1993	DNA restriction fragment length polymorphism among British isolates of Aujeszky's disease virus: use of the polymerase chain reaction to discriminate among strains
CA2226457A1 (en)	1996-12-12	Oligonucleotides specific for human papilloma virus
AU4136797A (en)	1998-04-02	Novel semaphorin gene: semaphorin y
Osterrieder et al.	1994	Expression of equine herpesvirus type 1 glycoprotein gp14 in Escherichia coli and in insect cells: a comparative study on protein processing and humoral immune responses
WO1999004029A3 (en)	1999-04-01	A swine hepatitis e virus and uses thereof
WO2000028039A3 (en)	2000-10-05	Identification of senv genotypes
ATE124991T1 (de)	1995-07-15	Humaner papillomvirus typ 57, seine dna und die davon kodierten proteine.